Company Registration No. 13876796 (England and Wales)
LIFE LINE PHARMA LTD
Unaudited accounts
for the year ended 31 January 2026
LIFE LINE PHARMA LTD
Unaudited accounts
Contents
LIFE LINE PHARMA LTD
Company Information
for the year ended 31 January 2026
Director
Andreea Elena NICHIFORIUC
Company Number
13876796 (England and Wales)
Registered Office
101 WHITECHAPEL ROAD
LONDON
E1 1DT
ENGLAND
Accountants
Khan Islam & Co
117 Whitechapel Road
3rd Floor
London
London
E1 1DT
LIFE LINE PHARMA LTD
Statement of financial position
as at 31 January 2026
Tangible assets
3,873
3,553
Cash at bank and in hand
59,199
43,632
Creditors: amounts falling due within one year
(13,738)
(3,460)
Net current assets
60,663
57,434
Total assets less current liabilities
64,536
60,987
Creditors: amounts falling due after more than one year
(52,580)
(53,529)
Called up share capital
900
900
Profit and loss account
11,056
6,558
Shareholders' funds
11,956
7,458
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 14 October 2026 and were signed on its behalf by
Andreea Elena NICHIFORIUC
Director
Company Registration No. 13876796
LIFE LINE PHARMA LTD
Notes to the Accounts
for the year ended 31 January 2026
LIFE LINE PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 13876796. The registered office is 101 WHITECHAPEL ROAD, LONDON, E1 1DT, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
LIFE LINE PHARMA LTD
Notes to the Accounts
for the year ended 31 January 2026
4
Tangible fixed assets
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 February 2025
3,988
1,050
5,038
At 31 January 2026
3,988
2,158
6,146
At 1 February 2025
1,107
378
1,485
Charge for the year
432
356
788
At 31 January 2026
1,539
734
2,273
At 31 January 2026
2,449
1,424
3,873
At 31 January 2025
2,881
672
3,553
Amounts falling due within one year
6
Creditors: amounts falling due within one year
2026
2025
Trade creditors
8,981
(1,892)
Taxes and social security
(235)
152
7
Creditors: amounts falling due after more than one year
2026
2025
Other creditors
32,800
32,800
Loans from directors
19,780
20,729
8
Average number of employees
During the year the average number of employees was 5 (2025: 5).